Centenial Surg. Sut.
Ticker > Company >

Centenial Surg. Sut. share price

Centenial Surgical Suture Ltd.

BSE: 531380 SECTOR: Medical Equipment/Supplies/Accessories  16.53 K   6   1

73.20
-1.30 (-1.74%)
BSE: 24 Jun 4:00 PM

Price Summary

Today's High

₹ 76.35

Today's Low

₹ 73.2

52 Week High

₹ 189

52 Week Low

₹ 73.04

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 26.71 Cr.

Enterprise Value

₹ 38.74 Cr.

No. of Shares

0.36 Cr.

P/E

0

P/B

1

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  73.39

CASH

₹ 0.22 Cr.

DEBT

₹ 12.26 Cr.

Promoter Holding

46.89 %

EPS (TTM)

₹  -6.04

Sales Growth

4.55%

ROE

-4.93 %

ROCE

5.09%

Profit Growth

-229.03 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Centenial Surgical Suture Ltd.

CENTILENE CENTLON CENTSILK CENTLINEN CENTIBOND CENTSTEEL CENTIDEENE CENTENIAL CENTICRYL MONOSYNTH CENTISORB

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year4.55%
3 Year6.4%
5 Year-0.77%

Profit Growth

1 Year-229.03%
3 Year-232.65%
5 Year-202.47%

ROE%

1 Year-4.93%
3 Year0.65%
5 Year1.54%

ROCE %

1 Year5.09%
3 Year7.33%
5 Year7.58%

Debt/Equity

0.3986

Price to Cash Flow

1.56

Interest Cover Ratio

0.5854

CFO/PAT (5 Yr. Avg.)

14.5902120717781

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2026 46.89 0.00
Dec 2025 46.89 0.00
Sep 2025 46.89 0.00
Jun 2025 46.89 0.00
Mar 2025 46.89 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

 Looks like the company does not have any notable strengths.

 Limitations

  • The company has shown a poor profit growth of -232.646318209255% for the Past 3 years.
  • The company has shown a poor revenue growth of 6.40134733175699% for the Past 3 years.
  • Company has a poor ROE of 0.646566666666667% over the past 3 years.
  • Company has low Interest coverage ratio of 0.5854.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 13.31 12.94 13.46 14.86 12.59
Total Expenditure 11.24 11.71 12.06 13.33 11.65
Operating Profit 2.07 1.23 1.4 1.53 0.94
Other Income 0.05 0 0.05 0.05 0.07
Interest 2.19 0.32 0.46 0.35 2.21
Depreciation 1.26 0.95 0.99 1.04 1.02
Exceptional Items 0 0 0 0 0
Profit Before Tax -1.34 -0.04 -0.01 0.2 -2.23
Tax -0.15 0 0 0.05 0.09
Profit After Tax -1.18 -0.04 -0.01 0.15 -2.31
Adjusted EPS (Rs) -3.24 -0.11 -0.03 0.4 -6.34

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 36.93 44.43 52.66 51.19 53.52
Total Expenditure 31.83 39.94 48.26 46.04 47.1
Operating Profit 5.11 4.48 4.4 5.15 6.42
Other Income 0.09 0.04 0.13 0.13 0.12
Interest 2.12 1.93 1.77 2.62 3.9
Depreciation 1.55 1.53 1.3 1.39 4.25
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.53 1.07 1.46 1.27 -1.62
Tax 0.57 0.45 0.58 0.14 -0.15
Net Profit 0.96 0.63 0.89 1.13 -1.46
Adjusted EPS (Rs.) 2.64 1.72 2.43 3.11 -4.01

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 5.42 5.42 5.42 5.42 5.42
Total Reserves 24.15 24.77 25.66 26.79 25.33
Borrowings 1.2 0 0 0 0
Other N/C liabilities 7.77 6.87 6.24 14.08 21.97
Current liabilities 31.5 24.27 29.07 32.85 31.83
Total Liabilities 70.04 61.34 66.4 79.15 84.56
Assets
Net Block 8.97 7.6 6.46 12.77 19.99
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0.32 0.41 0.42 0.71 1.34
Other N/C Assets 0.14 0.05 0.14 0.35 0.26
Current Assets 60.61 53.27 59.37 65.32 62.96
Total Assets 70.04 61.34 66.4 79.15 84.56
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 1.53 1.07 1.46 1.27 -1.62
Adjustment 3.62 3.43 2.98 4.08 8.14
Changes in Assets & Liabilities -2.61 0.55 -2.6 1.27 10.82
Tax Paid -0.57 -0.3 -0.55 -0.41 -0.27
Operating Cash Flow 1.97 4.75 1.3 6.21 17.07
Investing Cash Flow -0.89 -0.17 -0.18 -7.92 -11.61
Financing Cash Flow -1.27 -4.87 -1.05 2.06 -5.93
Net Cash Flow -0.18 -0.28 0.07 0.35 -0.47

Corporate Actions

Investors Details

PARTICULARS Mar 2025% Jun 2025% Sep 2025% Dec 2025% Mar 2026%
promoters 46.89 46.89 46.89 46.89 46.89
anuradha raghunandan kash... - 19.15 19.15 19.15 19.15
gaurav majrekar 5.12 5.12 5.12 5.12 5.12
vijay kalidas majrekar 22.62 22.62 22.62 22.62 22.62
anuradha kashikar 19.15 - - - -
PARTICULARS Mar 2025% Jun 2025% Sep 2025% Dec 2025% Mar 2026%
investors 53.11 53.11 53.11 53.11 53.11
birju harshad tanna 3.19 3.19 3.19 3.19 3.19
devendra k. kothari 9.46 9.46 9.46 9.46 9.46
dhanraj rajesh gala 1.16 1.16 1.16 1.16 1.16
kartik shyam kingar 16.70 16.70 16.70 16.70 16.70
parag himatlal sheth 3.97 3.97 3.97 3.97 3.97

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Centenial Surgical Suture informs about newspaper advertisement 3 Jun, 9:36 AM Centenial Surgical - Quaterly Results 12 Aug, 8:01 PM Centenial Surgical - Quaterly Results 12 Aug, 8:01 PM Centenial Surgical - Quaterly Results 14 Feb, 3:48 PM Centenial Surgical Suture informs about trading window closure 27 Dec, 2:20 PM Centenial Surgical - Quaterly Results 12 Aug, 3:56 PM Centenial Surgical - Quaterly Results 12 Aug, 3:56 PM Centenial Surgical - Quaterly Results 12 Aug, 3:56 PM Centenial Surgical - Quaterly Results 28 May, 4:55 PM Centenial Surgical - Quaterly Results 14 Feb, 7:51 PM Central Surgical Structure informs about newspaper advertisement 17 Nov, 9:57 AM Centenial Surgical Suture informs about disclosure 11 Sep, 2:32 PM Centenial Surgical Suture informs about disclosure 1 Mar, 11:32 AM Centenial Surgical - Quaterly Results 14 Feb, 3:49 PM Centenial Surgical Suture informs about loss of share certificate 24 Dec, 11:12 AM Centenial Surgical Suture informs about board meeting 5 Nov, 2:52 PM Centenial Surgical Suture informs about AGM proceedings 10 Aug, 12:31 PM Centenial Surgical Suture informs about voting results 10 Aug, 9:50 AM Centenial Surgical Suture informs about newspaper advertisement 15 Jul, 4:57 PM Centenial Surgical Suture informs about certificate 4 Jul, 12:59 PM Centenial Surgical Suture informs about outcome of board meeting 27 Jun, 4:04 PM Centenial Surgical Suture informs about voting results 1 Apr, 9:41 AM Centenial Surgical - Quaterly Results 10 Feb, 4:57 PM Centenial Surgical - Quaterly Results 10 Feb, 4:57 PM Centenial Surgical Suture informs about trading window closure 30 Sep, 3:27 PM Centenial Surgical Suture informs about disclosure 5 Feb, 3:31 PM Centenial Surgical Suture informs about board meeting 3 Nov, 5:14 PM Centenial Surgical Suture submits RTA certificate 6 Apr, 3:11 PM

Centenial Surg. Sut. Stock Price Analysis and Quick Research Report. Is Centenial Surg. Sut. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Centenial Surg. Sut.. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Centenial Surg. Sut. has a PE ratio of -12.111385032843 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Centenial Surg. Sut. has ROA of -1.7881% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Centenial Surg. Sut. has a Current ratio of 1.9782.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Centenial Surg. Sut. has a ROE of -4.9262%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Centenial Surg. Sut. has a Debt to Equity ratio of 0.3986 which means that the company has low proportion of debt in its capital.

  • Sales growth: Centenial Surg. Sut. has reported revenue growth of 4.5465% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Centenial Surg. Sut. for the current financial year is 11.9933777061899%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Centenial Surg. Sut. is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Centenial Surg. Sut. is Rs -6.0439. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Centenial Surg. Sut. in Ticker for free. Also, one can get the intrinsic value of Centenial Surg. Sut. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Centenial Surg. Sut. FAQs

Q1. What is Centenial Surg. Sut. share price today?
Ans: The current share price of Centenial Surg. Sut. is Rs 73.2.

Q2. What is the market capitalisation of Centenial Surg. Sut.?
Ans: Centenial Surg. Sut. has a market capitalisation of Rs 26.705556 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Centenial Surg. Sut.?
Ans: The PE ratio of Centenial Surg. Sut. is -12.111385032843 and the P/B ratio of Centenial Surg. Sut. is 0.997432836797096, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Centenial Surg. Sut. share?
Ans: The 52-week high share price of Centenial Surg. Sut. is Rs 189, and the 52-week low share price of Centenial Surg. Sut. is Rs 73.04.

Q5. Does Centenial Surg. Sut. pay dividends?
Ans: Currently, Centenial Surg. Sut. does not pay dividends. Dividend yield of Centenial Surg. Sut. is around 0%.

Q6. What are the face value and book value of Centenial Surg. Sut. shares?
Ans: The face value of Centenial Surg. Sut. shares is Rs 10, while the book value per share of Centenial Surg. Sut. is around Rs 73.3884. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Centenial Surg. Sut.?
Ans: Centenial Surg. Sut. has a total debt of Rs 12.2578 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Centenial Surg. Sut.?
Ans: The ROE of Centenial Surg. Sut. is -4.9262% and ROCE of Centenial Surg. Sut. is 5.0937%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Centenial Surg. Sut. a good buy for the long term?
Ans: The Centenial Surg. Sut. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Centenial Surg. Sut. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Centenial Surg. Sut. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Centenial Surg. Sut.’s financials?
Ans: You can review Centenial Surg. Sut.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Centenial Surg. Sut.
X